60 Degrees Pharmaceuticals Inc Share Price

NASDAQ: SXTP

Small Cap

$1.45

+0.01

(+0.35%)

as on September 18, 2025 at 1:29 am IST

$₹

60 Degrees Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$1.43
Day's Price Range
$1.47
$1.45
1.38%
Downside
1.38%
Upside
52 Week's Low
52 Week's High
$1.22
52-Week Price Range
$12.45
$1.45
16.21%
Downside
758.62%
Upside

60 Degrees Pharmaceuticals Inc share price movements today

Previous Close: $1.44
Open: $1.44
Volume: 538.1K
Day's Low - High: $1.43 - $1.47
52 Week Low - High: $1.22 - $12.45

60 Degrees Pharmaceuticals Inc Historical Returns

1 Month Return: + 9.09 %
3 Month Return: -30.43 %
1 Year Return: -80 %
3 Year Return: 0 %
5 Year Return: 0 %

60 Degrees Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check 60 Degrees Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.6M

EPS (TTM)

-2.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

19.57

Industry PE ratio

P/B Ratio

19.5714

PEG Ratio

EBITDA

-7.6M

Revenue (TTM)

984.5K

Profit Margin

0.00%

Return On Equity TTM

-294.87%

60 Degrees Pharmaceuticals Inc Stock Valuation

Track how 60 Degrees Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

60 Degrees Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (19.57x)

September 17, 2025

Highest (-0.35x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 19.57x

60 Degrees Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 60 Degrees Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
60 Degrees Pharmaceuticals Inc	BUY	$5.6M	NA	19.57	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for 60 Degrees Pharmaceuticals Inc Stock including INR - Dollar returns

The 60 Degrees Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

60 Degrees Pharmaceuticals Inc investment value today

Current value as on today

₹24,737

Returns

₹75,263

(-75.26%)

Returns from 60 Degrees Pharmaceuticals Inc Stock

₹79,861 (-79.86%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on 60 Degrees Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for 60 Degrees Pharmaceuticals Inc. Average target price of $3

60 Degrees Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on 60 Degrees Pharmaceuticals Inc.

What analysts predicted

51.67%UPSIDE

Target Price

Current Price

$1.45

Analyzed by

8 Analysts

Target

$3.00

60 Degrees Pharmaceuticals Inc target price $3, a slight upside of 51.67% compared to current price of $1.45. According to 8 analysts rating.

60 Degrees Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for 60 Degrees Pharmaceuticals Inc Stock has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-75% versus previous 30 day period

60 Degrees Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	0	-1	-1	-1	-4	-2	-2	-1	-1
EBITDA	-1	-2	4	-1	0	-4	-2	-2	-1	-1
Interest Expense	1	1	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-3	4	-2	0	-4	-2	-2	-1	-1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-2	-3	4	-1	0	-4	-2	-2	-1	-1
Net Profit Margin	-15141.28%	-5604.64%	8172.22%	-4584.98%	294.65%	-3319.61%	-1596.38%	-782.22%	-732.22%	-557.53%

60 Degrees Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	2	1	0	0	0
Gross Profit	1	0	0	0	0
Operating Income	0	-1	-1	-5	-9
EBITDA	0	-1	-2	-1	-7
Interest Expense	2	3	3	2	0
Depreciation	0	0	0	0	0
Income Before Tax	-3	-4	-6	-3	-7
Income Tax Expense	0	0	0	0	0
Net Income	-3	-4	-6	-3	-7
Net Profit Margin	-119.00%	-366.42%	-2769.49%	-1485.06%	-1166.39%

60 Degrees Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	4	-1	0	-4	-2	-2	-1	1
Operating Cash Flow	0	-3	0	-1	-1	-1	-1	-1	-1
Investing Cash Flow	0	0	-	0	0	-1	0	1	0
Financing Cash Flow	0	5	0	1	0	5	0	1	-
Change in Cash	0	2	0	0	-1	1	-1	1	-1

60 Degrees Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-6	-3	-7
Operating Cash Flow	0	-1	-4	-5
Investing Cash Flow	0	0	0	-1
Financing Cash Flow	0	1	6	7
Change in Cash	0	0	1	0

Insights on 60 Degrees Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 256.28K → 307.87K (in $), with an average increase of 16.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -4.17M → -1.71M (in $), with an average increase of 29.3% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 148.1%
NEGATIVE IMPACT
Price Dip
In the last 3 months, SXTP stock has moved down by -30.4%

About 60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Organisation	60 Degrees Pharmaceuticals Inc
Headquarters	1025 Connecticut Avenue NW, Washington, DC, United States, 20036
CEO	Dr. Geoffrey Stuart Dow Ph.D.
E-voting on shares	Click here to vote

Key Management of 60 Degrees Pharmaceuticals Inc

Name	Title
Dr. Geoffrey Stuart Dow Ph.D.	Chairman, CEO & President
Mr. Tyrone Miller	CFO & Treasurer
Ms. Kristen Landon	Chief Commercial Officer
Dr. Bryan Smith	Chief Medical Officer

FAQs

What is 60 Degrees Pharmaceuticals Inc share price today?

60 Degrees Pharmaceuticals Inc share price today is $1.45 as on September 18, 2025 at 1:29 am IST at the close of the market. 60 Degrees Pharmaceuticals Inc share today touched a day high of $1.47 and a low of $1.43.

What is the 52 week high and 52 week low for 60 Degrees Pharmaceuticals Inc share?

60 Degrees Pharmaceuticals Inc share touched a 52 week high of $12.45 on December 11, 2024 and a 52 week low of $1.22 on August 28, 2025. 60 Degrees Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $1.45,which is 88.35% down from its 52 week high and 19.34% up from its 52 week low.

What is 60 Degrees Pharmaceuticals Inc's market capitalisation today?

60 Degrees Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in 60 Degrees Pharmaceuticals Inc Stock (SXTP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 60 Degrees Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 60 Degrees Pharmaceuticals Inc Shares that will get you 1.0345 shares as per 60 Degrees Pharmaceuticals Inc share price of $1.45 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy 60 Degrees Pharmaceuticals Inc Stock (SXTP) from India?

Indian investors can start investing in 60 Degrees Pharmaceuticals Inc (SXTP) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in 60 Degrees Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 2:37 am IST). Based on 60 Degrees Pharmaceuticals Inc share’s latest price of $1.45 as on September 18, 2025 at 1:29 am IST, you will get 6.8966 shares of 60 Degrees Pharmaceuticals Inc. Learn more about fractional shares .